Journals / European Journal of Rheumatology / 2022 / Cilt: 9 - Sayı: 1

Clinical subgroup clustering analysis in a systemic lupus erythematosus cohort from Western Pennsylvania

Pages
3–7
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clustering analysis might help to better manage and predict disease complications in heterogenous diseases like lupus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Systemic lupus erythematosus (SLE) is a complex heterogenous autoimmune disease that can affect multiple organs.
📊
Key Findings & Data:Methods: A total of 724 patients who met the American College of Rheumatology (ACR) classification criteria for SLE were included in this study.
💡
Conclusion & Impact:Clustering analysis might help to better manage and predict disease complications in heterogenous diseases like lupus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Systemic lupus erythematosus (SLE) is a complex heterogenous autoimmune disease that can affect multiple organs. We performed clinical clustering analysis to describe a lupus cohort from the University of Pittsburgh Medical Center. Methods: A total of 724 patients who met the American College of Rheumatology (ACR) classification criteria for SLE were included in this study. Clustering was performed using the ACR classification criteria and the partitioning around medoid method. Correlation analysis was performed using the Spearman’s Rho test. Results: Patients with SLE in our cohort identify three district clinical disease subsets. Patients in cluster 1 were significantly more likely to develop renal and hematologic involvement, and had overrepresentation in African–American and male lupus patients. Clusters 2 and 3 identified a milder disease, with a significantly less likelihood of organ complications. Patients in cluster 2 are characterized by malar rash and photosensitivity, while patients in cluster 3 are characterized by oral ulcers, which is present in ~90% of patients within this cluster. The presence of photosensitivity or oral ulcers appears to be protective against the development of lupus nephritis in our cohort. Conclusion: We describe a large cohort of SLE from Western Pennsylvania and identify three distinct clinical disease subgroups. Clustering analysis might help to better manage and predict disease complications in heterogenous diseases like lupus.

🔖

Cite This Article

COIT, P., RUFFALO, L., SAWALHA, A. H. (2022). Clinical subgroup clustering analysis in a systemic lupus erythematosus cohort from Western Pennsylvania. European Journal of Rheumatology, Cilt: 9 - Sayı: 1, 3–7. https://ajindex.com/articles/511455

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020
  2. 21(6):605-14. [CrossRef] 2. Hughes T, Adler A, Merrill JT, et al. Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Ann Rheum Dis. 2012
  3. 71(5):694-99. [CrossRef] 3. Coit P, Ognenovski M, Gensterblum E, Maksimowicz- McKinnon K, Wren JD, Sawalha AH. Ethnicity-specific epigenetic variation in naive CD4+ T cells and the susceptibility to autoimmunity. Epigenet Chromatin. 2015
  4. [CrossRef] 4. Harley JB, Chen X, Pujato M, et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 2018
  5. 50(5):699-707. [CrossRef] 5. Weeding E, Sawalha AH. Deoxyribonucleic acid methylation in systemic lupus erythematosus: Implications for future clinical practice. Front Immunol. 2018
  6. [CrossRef] 6. Li H, Tsokos MG, Bickerton S, et al. Precision DNA demethylation ameliorates disease in lupusprone mice. JCI Insight. 2018
  7. 3(16):e120880. [CrossRef] 7. Sanchez E, Nadig A, Richardson BC, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011
  8. 70(10):1752-57. [CrossRef] 8. Coit P, Renauer P, Jeffries MA, Merrill JT, McCune WJ, Maksimowicz-McKinnon K, et al. Renal involvement in lupus is characterized by unique DNA methylation changes in naive CD4+ T cells. J Autoimmun. 2015
  9. [CrossRef] 9. Mok A, Solomon O, Nayak RR, et al. Genomewide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses. Lupus Sci Med. 2016
  10. 3(1):e000183. [CrossRef] 10. Renauer P, Coit P, Jeffries MA, et al. DNA methylation patterns in naive CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus Sci Med. 2015
  11. 2(1):e000101. [CrossRef] 11. Merrill JT, Manzi S, Aranow C, et al. Lupus community panel proposals for optimising clinical trials: 2018. Lupus Sci Med. 2018
  12. 5(1):e000258. [CrossRef] 12. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997
  13. 40(9):1725. [CrossRef] 13. Gower JC. A general coefficient of similarity and some of its properties. Biometrics. 1971
  14. 27(4):857-71. [CrossRef] 14. Charrad M, Ghazzali N, Boiteau V, Niknafs A. NbClust: An R package for deter